Table 2.
Univariate analysis (log-rank test).
| N. of patients | Overall survival | Disease free survival | Loco-regional control | |
|---|---|---|---|---|
| Age (y) | ||||
| <65 | 21 | p = 0.61 | p = 0.87 | p = 0.80 |
| ≥65 | 19 | |||
| Stage | ||||
| Stage IIA–IIB | 16 | p = 0.28 | p = 0.66 | p = 0.65 |
| Stage III | 21 | |||
| Stage IV | 3 | |||
| N category | ||||
| N0 | 24 | p = 0.83 | p = 0.31 | p = 0.30 |
| N1 | 16 | |||
| Histological grading | ||||
| G < 3 | 22 | p = 0.30 | p = 0.38 | p = 0.29 |
| G = 3 | 18 | |||
| Response to treatment | ||||
| Complete response | 20 | p = 0.11 | p = 0.0006 | p = 0.0003 |
| Partial response | 8 | |||
| No response | 8 | |||
| Complete response | 20 | p = 0.32 | p = 0.0001 | p = 0.0001 |
| Partial response + no response | 16 | |||
| Dose (Gy) | ||||
| <60 Gy | 26 | p = 0.53 | p = 0.06 | p = 0.02 |
| ≥60 Gy | 14 | |||